Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Kent Hutchison to Genotype

This is a "connection" page, showing publications Kent Hutchison has written about Genotype.

 
Connection Strength
 
 
 
1.527
 
  1. Blaine S, Claus E, Harlaar N, Hutchison K. TACR1 genotypes predict fMRI response to alcohol cues and level of alcohol dependence. Alcohol Clin Exp Res. 2013 Jan; 37 Suppl 1:E125-30.
    View in: PubMed
    Score: 0.278
  2. Feldstein Ewing SW, LaChance HA, Bryan A, Hutchison KE. Do genetic and individual risk factors moderate the efficacy of motivational enhancement therapy? Drinking outcomes with an emerging adult sample. Addict Biol. 2009 Jul; 14(3):356-65.
    View in: PubMed
    Score: 0.217
  3. Hutchison KE, Stallings M, McGeary J, Bryan A. Population stratification in the candidate gene study: fatal threat or red herring? Psychol Bull. 2004 Jan; 130(1):66-79.
    View in: PubMed
    Score: 0.151
  4. Ray LA, Courtney KE, Hutchison KE, Mackillop J, Galvan A, Ghahremani DG. Initial evidence that OPRM1 genotype moderates ventral and dorsal striatum functional connectivity during alcohol cues. Alcohol Clin Exp Res. 2014 Jan; 38(1):78-89.
    View in: PubMed
    Score: 0.073
  5. Bryan AD, Hutchison KE. The role of genomics in health behavior change: challenges and opportunities. Public Health Genomics. 2012; 15(3-4):139-45.
    View in: PubMed
    Score: 0.067
  6. Hendershot CS, Bryan AD, Ewing SW, Claus ED, Hutchison KE. Preliminary evidence for associations of CHRM2 with substance use and disinhibition in adolescence. J Abnorm Child Psychol. 2011 Jul; 39(5):671-81.
    View in: PubMed
    Score: 0.064
  7. Filbey FM, Claus ED, Morgan M, Forester GR, Hutchison K. Dopaminergic genes modulate response inhibition in alcohol abusing adults. Addict Biol. 2012 Nov; 17(6):1046-56.
    View in: PubMed
    Score: 0.063
  8. Sher KJ, Dick DM, Crabbe JC, Hutchison KE, O'Malley SS, Heath AC. Consilient research approaches in studying gene x environment interactions in alcohol research. Addict Biol. 2010 Apr; 15(2):200-16.
    View in: PubMed
    Score: 0.058
  9. Duncan LE, Hutchison KE, Carey G, Craighead WE. Variation in brain-derived neurotrophic factor (BDNF) gene is associated with symptoms of depression. J Affect Disord. 2009 May; 115(1-2):215-9.
    View in: PubMed
    Score: 0.053
  10. Ray LA, Bryan A, Mackillop J, McGeary J, Hesterberg K, Hutchison KE. The dopamine D Receptor (DRD4) gene exon III polymorphism, problematic alcohol use and novelty seeking: direct and mediated genetic effects. Addict Biol. 2009 Apr; 14(2):238-44.
    View in: PubMed
    Score: 0.052
  11. Haughey HM, Marshall E, Schacht JP, Louis A, Hutchison KE. Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes. Addiction. 2008 Oct; 103(10):1678-86.
    View in: PubMed
    Score: 0.052
  12. Filbey FM, Ray L, Smolen A, Claus ED, Audette A, Hutchison KE. Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes. Alcohol Clin Exp Res. 2008 Jul; 32(7):1113-23.
    View in: PubMed
    Score: 0.052
  13. Hutchison KE, Haughey H, Niculescu M, Schacht J, Kaiser A, Stitzel J, Horton WJ, Filbey F. The incentive salience of alcohol: translating the effects of genetic variant in CNR1. Arch Gen Psychiatry. 2008 Jul; 65(7):841-50.
    View in: PubMed
    Score: 0.052
  14. Haughey HM, Ray LA, Finan P, Villanueva R, Niculescu M, Hutchison KE. Human gamma-aminobutyric acid A receptor alpha2 gene moderates the acute effects of alcohol and brain mRNA expression. Genes Brain Behav. 2008 Jun; 7(4):447-54.
    View in: PubMed
    Score: 0.050
  15. Ray LA, Hutchison KE. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch Gen Psychiatry. 2007 Sep; 64(9):1069-77.
    View in: PubMed
    Score: 0.049
  16. Hutchison KE, Allen DL, Filbey FM, Jepson C, Lerman C, Benowitz NL, Stitzel J, Bryan A, McGeary J, Haughey HM. CHRNA4 and tobacco dependence: from gene regulation to treatment outcome. Arch Gen Psychiatry. 2007 Sep; 64(9):1078-86.
    View in: PubMed
    Score: 0.049
  17. Bryan A, Hutchison KE, Seals DR, Allen DL. A transdisciplinary model integrating genetic, physiological, and psychological correlates of voluntary exercise. Health Psychol. 2007 Jan; 26(1):30-9.
    View in: PubMed
    Score: 0.047
  18. Hoefer ME, Pennington DL, Durazzo TC, Mon A, Ab? C, Truran D, Hutchison KE, Meyerhoff DJ. Genetic and behavioral determinants of hippocampal volume recovery during abstinence from alcohol. Alcohol. 2014 Nov; 48(7):631-8.
    View in: PubMed
    Score: 0.020
  19. Schacht JP, Hutchison KE, Filbey FM. Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users. Neuropsychopharmacology. 2012 Oct; 37(11):2368-76.
    View in: PubMed
    Score: 0.017
  20. Doll BB, Hutchison KE, Frank MJ. Dopaminergic genes predict individual differences in susceptibility to confirmation bias. J Neurosci. 2011 Apr 20; 31(16):6188-98.
    View in: PubMed
    Score: 0.016
  21. Hoft NR, Stitzel JA, Hutchison KE, Ehringer MA. CHRNB2 promoter region: association with subjective effects to nicotine and gene expression differences. Genes Brain Behav. 2011 Mar; 10(2):176-85.
    View in: PubMed
    Score: 0.015
  22. McClernon FJ, Hutchison KE, Rose JE, Kozink RV. DRD4 VNTR polymorphism is associated with transient fMRI-BOLD responses to smoking cues. Psychopharmacology (Berl). 2007 Nov; 194(4):433-41.
    View in: PubMed
    Score: 0.012
  23. van den Wildenberg E, Janssen RG, Hutchison KE, van Breukelen GJ, Wiers RW. Polymorphisms of the dopamine D4 receptor gene (DRD4 VNTR) and cannabinoid CB1 receptor gene (CNR1) are not strongly related to cue-reactivity after alcohol exposure. Addict Biol. 2007 Jun; 12(2):210-20.
    View in: PubMed
    Score: 0.012
  24. David SP, Niaura R, Papandonatos GD, Shadel WG, Burkholder GJ, Britt DM, Day A, Stumpff J, Hutchison K, Murphy M, Johnstone E, Griffiths SE, Walton RT. Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome? Nicotine Tob Res. 2003 Dec; 5(6):935-42.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)